Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
NCT00832689
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Biliary Tract Cancer
Interventions
DRUG:
Irinotecan and Gemcitabine
Sponsor
Yonsei University